X0306 4 2015-11-02 1 0000815065 STERIS CORP STE 0001235611 TOKICH MICHAEL J C/O 5960 HEISLEY ROAD MENTOR OH 44060 0 1 0 0 SVP, CFO & Treasurer Common Shares, No Par Value 2015-11-02 4 D 0 39128 D 0 D Common Shares, No Par Value 2015-11-02 4 D 0 3069 D 0 I See Footnote Below. Employee Stock Option (right to buy) 27.45 2015-11-02 4 D 0 2000 D 2017-11-01 Common Shares, No Par Value 2000 0 D Employee Stock Option (right to buy) 26.41 2015-11-02 4 D 0 13600 D 2018-03-14 Common Shares, No Par Value 13600 0 D Employee Stock Option (right to buy) 22.83 2015-11-02 4 D 0 12000 D 2019-05-21 Common Shares, No Par Value 12000 0 D Employee Stock Option (right to buy) 31.87 2015-11-02 4 D 0 11000 D 2020-05-20 Common Shares, No Par Value 11000 0 D Employee Stock Option (right to buy) 36.09 2015-11-02 4 D 0 14500 D 2021-05-31 Common Shares, No Par Value 14500 0 D Employee Stock Option (right to buy) 29.94 2015-11-02 4 D 0 20000 D 2022-05-30 Common Shares, No Par Value 20000 0 D Employee Stock Option (right to buy) 45.34 2015-11-02 4 D 0 22000 D 2023-05-31 Common Shares, No Par Value 22000 0 D Employee Stock Option (right to buy) 53.52 2015-11-02 4 D 0 28000 D 2024-05-30 Common Shares, No Par Value 28000 0 D Employee Stock Option (right to buy) 67.98 2015-11-02 4 D 0 20000 D 2025-08-10 Common Shares, No Par Value 20000 0 D 25,500 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 7,000 on May 31, 2016; 7,000 on May 31, 2017; 4,500 on May 30, 2018; and 7,000 on May 28, 2019. Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share. Represents 3,139.323 units of the STERIS Corporation 401(k) Plan STERIS Stock Fund which equals 3,069 Common share equivalents as of October 29, 2015. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 2,000 ordinary shares of New STERIS for $27.45 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 13,600 ordinary shares of New STERIS for $26.41 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 12,000 ordinary shares of New STERIS for $22.83 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 11,000 ordinary shares of New STERIS for $31.87 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 14,500 ordinary shares of New STERIS for $36.09 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 5,000 on May 30, 2016. This option was assumed by New STERIS in the Merger and converted to an option to purchase 20,000 ordinary shares of New STERIS for $29.94 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 5,500 on May 31, 2016, and 5,500 on May 31, 2017. This option was assumed by New STERIS in the Merger and converted to an option to purchase 22,000 ordinary shares of New STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 7,000 on May 30, 2016; 7,000 on May 30, 2017 and 7,000 on May 30, 2018. This option was assumed by New STERIS in the Merger and converted to an option to purchase 28,000 ordinary shares of New STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original STERIS option. This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by New STERIS in the Merger and converted to an option to purchase 20,000 ordinary shares of New STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original STERIS option. /s/ Dennis P. Patton, Authorized Representative under Power of Attorney 2015-11-02